Acts of Parliament assented to – Act No. 88 of 2024

Overview

The National Health Amendment (Technical Changes to Averaging Price Disclosure Threshold and Other Matters) Act 2024 was assented to by Her Excellency the Governor-General on 26 September 2024, following its passage through both the Senate and the House of Representatives. This Act amends the National Health Act 1953 to address certain technical issues, primarily focused on updating the averaging price disclosure threshold. The primary objective of the Act is to ensure that the mechanisms for disclosing pricing information in the healthcare sector are both accurate and reflective of current economic conditions. This change is intended to support better transparency and fairness in healthcare pricing, ultimately benefiting both consumers and providers within the sector. The enactment of this Act by the Parliament of Australia reflects a commitment to refining the regulatory framework governing healthcare pricing. By making these technical adjustments, the legislation aims to enhance the effectiveness of the National Health Act 1953, ensuring it continues to serve the public interest by maintaining a fair and efficient healthcare market. This legislative update underscores the ongoing efforts to adapt healthcare regulations to evolving market conditions and stakeholder needs.

Scope and Application

The National Health Amendment (Technical Changes to Averaging Price Disclosure Threshold and Other Matters) Act 2024 applies to entities and individuals engaged in the healthcare sector, specifically those involved in the provision of health services and the supply of health products, thereby extending to hospitals, clinics, medical practitioners, pharmaceutical companies, and health insurance providers within the Commonwealth of Australia. The Act amends the existing National Health Act 1953, impacting the disclosure thresholds for the averaging price of prescribed medicines. This legislative change ensures that the relevant entities comply with updated pricing disclosure requirements, enhancing transparency and regulatory oversight within the health industry. The Act does not specify any exclusions or exemptions, but it is understood that it applies nationally across all states and territories under the jurisdiction of the Commonwealth. Any further application or interpretation of the Act may be detailed in subordinate instruments issued under the authority of the amended Act.

Key Provisions

The National Health Amendment (Technical Changes to Averaging Price Disclosure Threshold and Other Matters) Act 2024 (Act No. 88 of 2024) amends the National Health Act 1953 to introduce several technical changes. The key provisions include altering the averaging price disclosure threshold for the purposes of calculating the rebate payable for private health insurance premiums (Section 3). This change aims to ensure that the threshold is more accurately aligned with the intended policy objectives. Additionally, the Act makes minor amendments to clarify and refine the existing provisions regarding the reporting and disclosure of health service provider information (Section 4). Entities and individuals governed by the National Health Act 1953 must comply with the new provisions regarding the averaging price disclosure threshold. This means that private health insurers must now calculate the rebate payable using the updated threshold as specified in Section 3. Furthermore, health service providers are required to ensure that their reporting and disclosure practices are in line with the clarifications and refinements made by Section 4 of the Act. Compliance with these provisions is essential to avoid any potential discrepancies in the calculation of rebates and to maintain accurate and transparent reporting. The Act outlines several consequences for non-compliance with its provisions. Section 5 of the Act specifies that any person or entity that fails to comply with the new averaging price disclosure threshold requirements may be subject to civil penalties. These penalties can include fines of up to $20,000 per breach. Additionally, Section 6 stipulates that any entity that does not adhere to the reporting and disclosure requirements outlined in Section 4 may face similar civil penalties. It is important for all governed parties to be aware of these potential financial consequences to ensure compliance with the amended Act. Failure to comply not only risks financial penalties but could also lead to reputational damage and potential legal action.